Taghavi, Sahar <br/><br/>
Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.  [electronic resource] 

 -  Cancer letters  08 2017 
 - 1-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2017.04.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adsorption<br/>Animals<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Aptamers, Nucleotide--administration & dosage<br/>CHO Cells<br/>Cell Survival--drug effects<br/>Chitosan--analogs & derivatives<br/>Colonic Neoplasms--drug therapy<br/>Cricetulus<br/>Drug Carriers<br/>Drug Compounding<br/>Drug Liberation<br/>Epirubicin--administration & dosage<br/>Female<br/>Humans<br/>Lactic Acid--chemistry<br/>MCF-7 Cells<br/>Mice, Inbred BALB C<br/>Mucin-1--genetics<br/>Nanomedicine<br/>Nanoparticles<br/>Polyglycolic Acid--chemistry<br/>Polylactic Acid-Polyglycolic Acid Copolymer<br/>Solubility<br/>Surface Properties<br/>Technology, Pharmaceutical--methods<br/>Time Factors<br/>Tumor Burden--drug effects